2007
DOI: 10.1016/j.ajic.2007.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and molecular epidemiology of community-onset, extended-spectrum β-lactamase-producing Escherichia coli infections in Thailand: A case-case-control study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
59
2

Year Published

2008
2008
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 78 publications
(68 citation statements)
references
References 40 publications
7
59
2
Order By: Relevance
“…3 It is well recognized that antimicrobialresistant pathogens are a common cause of hospitalacquired infections; however, an increasing number of community-onset extended-spectrum beta-lactamase (ESBL)-producing bacterial infections, especially those caused by ESBL-Enterobacteriaceae, have been reported in many countries, including Thailand. [4][5][6][7][8][9] Risk factors for acquiring community-onset ESBL-producing Escherichia coli infections in Thailand include prior colonization with the bacterium and previous exposure to third-generation cephalosporins and fluoroquinolones. 9 Fecal carriage of ESBL-producing enterobacteria has increased significantly worldwide, with developing countries (especially in South and Southeast Asia) being the most affected.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…3 It is well recognized that antimicrobialresistant pathogens are a common cause of hospitalacquired infections; however, an increasing number of community-onset extended-spectrum beta-lactamase (ESBL)-producing bacterial infections, especially those caused by ESBL-Enterobacteriaceae, have been reported in many countries, including Thailand. [4][5][6][7][8][9] Risk factors for acquiring community-onset ESBL-producing Escherichia coli infections in Thailand include prior colonization with the bacterium and previous exposure to third-generation cephalosporins and fluoroquinolones. 9 Fecal carriage of ESBL-producing enterobacteria has increased significantly worldwide, with developing countries (especially in South and Southeast Asia) being the most affected.…”
Section: Introductionmentioning
confidence: 99%
“…[4][5][6][7][8][9] Risk factors for acquiring community-onset ESBL-producing Escherichia coli infections in Thailand include prior colonization with the bacterium and previous exposure to third-generation cephalosporins and fluoroquinolones. 9 Fecal carriage of ESBL-producing enterobacteria has increased significantly worldwide, with developing countries (especially in South and Southeast Asia) being the most affected. In these isolates, CTX-M enzymes are the dominant type of ESBL.…”
Section: Introductionmentioning
confidence: 99%
“…In the past decade, CTX-M-type ESBLs have replaced TEM-and SHV-type ESBLs in Europe, Canada, and Asia as the most common ESBL type in this species (1,4,19,22,25,30). The United States initially appeared immune to this epidemic of CTX-Mtype ESBLs.…”
mentioning
confidence: 99%
“…However, no resistance was determined to trimethoprim-sulfamethoxazole in these strains and that can be explained by repeated antibiotic use in patients with chronic obstructive pulmonary disease that usually includes betalactams and quinolones, and not trimethoprim-sulfamethoxazole. These antibiotics lead to the development of resistance to many antibiotics especially in Gram-negative bacilli (27,28).…”
Section: Discussionmentioning
confidence: 99%